Buscar
Incannex Healthcare Inc
IXHLAñadir a la lista de seguimiento
3.280USD
+0.120+3.80%
Cierre 08-14 16:00（ET）Cotizaciones retrasadas 15 min
44.88MCap. mercado
PérdidaP/E TTM
Más Datos de Incannex Healthcare Inc Compañía
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing combination medicines that target the underlying biological pathways associated with chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalized anxiety disorder. Its lead clinical program, IHL-42X, is an oral fixed-dose combination of dronabinol and acetazolamide designed to target underlying mechanisms and act synergistically in the treatment of obstructive sleep apnoea. IHL-42X has completed a Phase II clinical trial. PSX-001 is a synthetic psilocybin treatment for the treatment of generalized anxiety disorder. PSX-001 has completed a Phase II clinical trial. IHL-675A is an oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate designed to act synergistically to alleviate inflammatory conditions, such as rheumatoid arthritis. IHL-675A is in a Phase II clinical development program.
Perfil de Incannex Healthcare Inc
Símbolo de cotizaciónIXHL
Nombre de la empresaIncannex Healthcare Inc
Fecha de salida a bolsaMar 18, 2022
Director ejecutivoLatham (Joel)
Número de empleados12
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 18
Dirección8 Century Circuit
Ciudad
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísAustralia
Código postal2153
Teléfono61409840786
Sitio Web
Símbolo de cotizaciónIXHL
Fecha de salida a bolsaMar 18, 2022
Director ejecutivoLatham (Joel)
Ejecutivos de Incannex Healthcare Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
806.21K
+93.48%
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
806.21K
+93.48%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
85.81K
+99.30%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
85.81K
+99.30%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
81.89K
+68.67%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
81.89K
+68.67%
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
65.26K
+86.17%
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
65.26K
+86.17%
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
21.32K
--
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
21.32K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
806.21K
+93.48%
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
806.21K
+93.48%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
85.81K
+99.30%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
85.81K
+99.30%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
81.89K
+68.67%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
81.89K
+68.67%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Incannex Healthcare Inc?
Los cinco principales accionistas de Incannex Healthcare Inc son: Mr. Joel Latham
¿Cuántas instituciones poseen acciones de Incannex Healthcare Inc (IXHL)?
A fecha de 2026Q1, 52 instituciones poseen acciones de Incannex Healthcare Inc, con un valor de mercado combinado de aproximadamente 501.46K, lo que representa el 3.59% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 248085.00.